Fundraising Fox
Macrotope
Princeton, US · Delaware corporation · 1 known investors
Find your way into Macrotope
Sign up to see every warm intro you have to Macrotope
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Macrotope team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$900K disclosed across 3 rounds · 2022–2025
▶$400KraisedMay 2025 · 1 investors · PharmaceuticalsRule 506(b)
▶$400KraisedMay 2025 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Elliot CamptbellExecutive Officer, Director
- Stephen AndersonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $400K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedAug 2023 · 1 investors · Other Health CareRule 506(b)
▶$300KraisedAug 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen AndersonExecutive Officer, Director
- Elliot CampbellExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $300K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$200KraisedJun 2022 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedJun 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen AndersonExecutive Officer, Director
- Elliot CampbellDirector
- Offering amount
- $750K
- Amount sold
- $200K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Macrotope.
Frequently asked questions
- What does Macrotope do?
- Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.
- Who founded Macrotope?
- Macrotope was founded by Stephen Anderson, Elliot Campbell.
- Who are Macrotope's investors?
- Macrotope's investors include Johnston Associates Inc..
- How much funding has Macrotope raised?
- Macrotope has disclosed $900K raised across 3 rounds.
- Where is Macrotope headquartered?
- Macrotope is headquartered in Princeton, US.